AR and prostate carcinoma: So far, have been described different point mutations, deletions or insertions at the level of the AR gene that influence the activity of AR in different diseases, such as complete androgen insensitivity syndrome (CAIS) [44], partial androgen insensitivity syndrome (Reifenstein syndrome) [45] or prostate cancer [44].